Stephen Betz

Stephen Betz

Net worth: 2 M $ as of 2026-05-30

60 year
Health Technology
Consumer Services

Profile

Stephen F.
Betz
is the founder of Crinetics Pharmaceuticals, Inc., founded in 2008, where the title held is Chief Scientific Officer since 2021.
Former jobs include Director-Endocrinology & Metabolism at Neurocrine Biosciences, Inc. from 2003 to 2009, and Head-Laboratory Efforts at GeneFormatics, Inc. from 2001 to 2003.
Education history includes an undergraduate degree from the University of Delaware conferred in 1987 and a doctorate from The University of North Carolina at Chapel Hill conferred in 1993.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-19 57,451 ( 0.05% ) 2 M $ 2026-05-30

Stephen Betz active positions

CompaniesPositionStart
CRINETICS PHARMACEUTICALS, INC. Founder 2007-12-31

Former positions of Stephen Betz

CompaniesPositionEnd
NEUROCRINE BIOSCIENCES, INC. Corporate Officer/Principal 2009-04-30
Corporate Officer/Principal 2002-12-31
See the detail of Stephen Betz's experience

Training of Stephen Betz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology